| 1 Number with incontinence within first year (subjective) |
6 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 1.1 Urodynamic diagnosis |
6 |
576 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.46 [0.30, 0.72] |
| 1.2 Symptom diagnosis |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 2 Number with incontinence after first year but before five years (subjective) |
7 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 2.1 Urodynamic diagnosis |
7 |
628 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.37 [0.27, 0.51] |
| 2.2 Symptom diagnosis |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 3 Number with incontinence after five years (subjective) |
3 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 3.1 Urodynamic diagnosis |
3 |
174 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.49 [0.32, 0.75] |
| 3.2 Symptom diagnosis |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 4 Number with incontinence within the first year (objective) |
4 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 4.1 Urodynamic diagnosis |
4 |
428 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.36 [0.22, 0.58] |
| 4.2 Symptom diagnosis |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 5 Number with incontinence after first and before five years (objective) |
6 |
505 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.34 [0.25, 0.47] |
| 5.1 Urodynamic diagnosis |
6 |
505 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.34 [0.25, 0.47] |
| 5.2 Symptom diagnosis |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 6 Number with incontinence at and after five years (objective) |
3 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 6.1 Urodynamic diagnosis |
3 |
174 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.48 [0.31, 0.73] |
| 6.2 Symptom diagnosis |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 7 Volume/weight of urine loss in 2 hour pad test |
1 |
45 |
Mean Difference (IV, Fixed, 95% CI) |
1.10 [‐4.41, 6.61] |
| 7.1 Urodynamic diagnosis |
1 |
45 |
Mean Difference (IV, Fixed, 95% CI) |
1.10 [‐4.41, 6.61] |
| 7.2 Symptom diagnosis |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 8 Condition specific health measure |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
| 8.1 Urodynamic diagnosis |
1 |
35 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.59 [‐1.11, ‐0.07] |
| 8.2 Symptom diagnosis |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 9 Operative time (minutes) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
| 9.1 Urodynamic diagnosis |
1 |
51 |
Mean Difference (IV, Fixed, 95% CI) |
14.4 [5.43, 23.37] |
| 9.2 Symptom diagnosis |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 10 Length of hospital stay (days) |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 10.1 Urodynamic diagnosis |
2 |
113 |
Mean Difference (IV, Random, 95% CI) |
‐1.53 [‐4.45, 1.39] |
| 10.2 Symptom diagnosis |
0 |
0 |
Mean Difference (IV, Random, 95% CI) |
0.0 [0.0, 0.0] |
| 11 Time to catheter removal (days) |
3 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
| 11.1 Urodynamic diagnosis |
3 |
324 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.28 [‐0.83, 0.27] |
| 11.2 Symptom diagnosis |
0 |
0 |
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 12 Number of perioperative surgical complications |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 12.1 Urodynamic diagnosis |
2 |
96 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.39 [0.19, 0.83] |
| 12.2 Symptom diagnosis |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 13 Number with de novo urge symptoms and urge incontinence |
3 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 13.1 Urodynamic diagnosis |
3 |
241 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.53 [0.25, 1.14] |
| 13.2 Symptom diagnosis |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 14 Number with de novo detrusor instability |
4 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 14.1 Urodynamic diagnosis |
4 |
306 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.26 [0.54, 2.94] |
| 14.2 Symptom diagnosis |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 15 Number with voiding difficulty |
4 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
| 15.1 Urodynamic diagnosis |
4 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 15.2 Symptom diagnosis |
0 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 16 Number with new or recurrent prolapse |
5 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
| 16.1 Urodynamic diagnosis |
5 |
447 |
Risk Ratio (M‐H, Random, 95% CI) |
2.51 [0.62, 10.10] |
| 16.2 Symptom diagnosis |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
| 17 Number with repeat anti‐incontinence surgery |
3 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 17.1 Urodynamic diagnosis |
3 |
271 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.11 [0.04, 0.30] |
| 17.2 Symptom diagnosis |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 18 Number with other complication inherent to procedure |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 18.1 Urodynamic diagnosis |
2 |
119 |
Risk Ratio (M‐H, Fixed, 95% CI) |
4.78 [0.58, 39.54] |
| 18.2 Symptom diagnosis |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
| 19 Number not cured within first year (subjective) Burch vs MMK |
6 |
|
Odds Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 19.1 Burch trials |
4 |
427 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.47 [0.26, 0.85] |
| 19.2 MMK trials |
2 |
146 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.58 [0.25, 1.36] |
| 20 Number not cured after first year but before five years (subjective) Burch vs MMK |
2 |
146 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.77 [0.38, 1.55] |
| 20.1 MMK |
2 |
146 |
Odds Ratio (M‐H, Fixed, 95% CI) |
0.77 [0.38, 1.55] |
